232 related articles for article (PubMed ID: 30463372)
1. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
Shen WJ; Zhang X; Zhang S; Liu C; Cui W
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
[TBL] [Abstract][Full Text] [Related]
2. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
3. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
Bordner AJ; Mittelmann HD
BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
[TBL] [Abstract][Full Text] [Related]
4. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.
Greenbaum J; Sidney J; Chung J; Brander C; Peters B; Sette A
Immunogenetics; 2011 Jun; 63(6):325-35. PubMed ID: 21305276
[TBL] [Abstract][Full Text] [Related]
5. Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
[TBL] [Abstract][Full Text] [Related]
6. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
Xu Y; Luo C; Qian M; Huang X; Zhu S
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
[TBL] [Abstract][Full Text] [Related]
7. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
[TBL] [Abstract][Full Text] [Related]
8. In silico identification of supertypes for class II MHCs.
Doytchinova IA; Flower DR
J Immunol; 2005 Jun; 174(11):7085-95. PubMed ID: 15905552
[TBL] [Abstract][Full Text] [Related]
9. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
Bordner AJ
PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
[TBL] [Abstract][Full Text] [Related]
10. Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules.
Zhu S; Udaka K; Sidney J; Sette A; Aoki-Kinoshita KF; Mamitsuka H
Bioinformatics; 2006 Jul; 22(13):1648-55. PubMed ID: 16613909
[TBL] [Abstract][Full Text] [Related]
11. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
Salomon J; Flower DR
BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
[TBL] [Abstract][Full Text] [Related]
12. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
Nielsen M; Lundegaard C; Lund O
BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
[TBL] [Abstract][Full Text] [Related]
13. Stoichiometry of HLA class II-invariant chain oligomers.
Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
[TBL] [Abstract][Full Text] [Related]
14. Consensus classification of human leukocyte antigen class II proteins.
Saha I; Mazzocco G; Plewczynski D
Immunogenetics; 2013 Feb; 65(2):97-105. PubMed ID: 23229472
[TBL] [Abstract][Full Text] [Related]
15. Definition of supertypes for HLA molecules using clustering of specificity matrices.
Lund O; Nielsen M; Kesmir C; Petersen AG; Lundegaard C; Worning P; Sylvester-Hvid C; Lamberth K; Røder G; Justesen S; Buus S; Brunak S
Immunogenetics; 2004 Mar; 55(12):797-810. PubMed ID: 14963618
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into human MHC-II association with invariant chain.
Wang N; Waghray D; Caveney NA; Jude KM; Garcia KC
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2403031121. PubMed ID: 38687785
[TBL] [Abstract][Full Text] [Related]
17. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
Jørgensen KW; Buus S; Nielsen M
PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis.
Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY
Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817
[TBL] [Abstract][Full Text] [Related]
19. Binding interactions between peptides and proteins of the class II major histocompatibility complex.
McFarland BJ; Beeson C
Med Res Rev; 2002 Mar; 22(2):168-203. PubMed ID: 11857638
[TBL] [Abstract][Full Text] [Related]
20. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
Herrmann T; Accolla RS; MacDonald HR
Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]